Harvard spinout eGenesis launched in 2015 in a bid to find a successful mechanism for transplanting pig organs into human beings.
EGenesis, a US-based genetics technology spinout from Harvard University, has raised $38m in a series A round backed by healthcare services provider Heritage Provider Network.
The round was co-led by Biomatics Capital and Arch Venture Partners, while Alexandria Venture Investments, the venture capital arm of property developer Alexandria Real Estate Equities, also took part along with Khosla Ventures, Alta Partners, Berggruen Holdings North America, Uprising and Fan Ventures.
Founded in 2015, eGenesis is working on genome editing technology that enables…
